CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue:
Total revenue		$ 2,264	$ 0	$ 2,264	$ 0
Operating expenses:
Cost of product revenue		88	0	88	0
Research and development	[1]	30,334	43,618	61,494	70,819
Acquired in-process research and development	[2]	0	150	0	975
Selling, general and administrative		21,089	10,107	36,018	21,152
Total operating costs and expenses		51,511	53,875	97,600	92,946
Loss from operations		(49,247)	(53,875)	(95,336)	(92,946)
Other income:
Other income, net		2,000	3,647	4,593	7,397
Total other income, net		2,000	3,647	4,593	7,397
Net loss		(47,247)	(50,228)	(90,743)	(85,549)
Other comprehensive income (loss)
Unrealized gain on available-for-sale securities, net of tax		0	93	1	250
Comprehensive loss		$ (47,247)	$ (50,135)	$ (90,742)	$ (85,299)
Net loss per share attributable to common stockholders, basic		$ (0.4)	$ (0.46)	$ (0.77)	$ (0.78)
Net loss per share attributable to common stockholders,diluted		$ (0.4)	$ (0.46)	$ (0.77)	$ (0.78)
Weighted-average common shares outstanding, basic		119,362,670	109,450,071	117,490,439	109,119,630
Weighted-average common shares outstanding, diluted		119,362,670	109,450,071	117,490,439	109,119,630
Product revenue
Revenue:
Total revenue		$ 2,264	$ 0	$ 2,264	$ 0

[1] Includes related-party amounts of $1,131 and $2,266 for the three and six months ended June 30, 2024, respectively, and $2,258 and $5,218 for the three and six months ended June 30, 2023, respectively (see Note 15).

[2] Includes no related-party amounts for both the three and six months ended June 30, 2024, and $0 and $375 for the three and six months ended June 30, 2023, respectively (see Note 15).